(Q33916200)

English

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

author name string

J L Rouleau

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M A Pfeffer

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D J Stewart

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Isaac

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

F Sestier

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

E K Kerut

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C B Porter

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

G Proulx

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

C Qian

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A J Block

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

356

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9230

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

615-620

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial and brain natriuretic peptides in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic dual inhibition of angiotensin-converting enzyme and neutral endopeptidase during the development of left ventricular dysfunction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902602-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02602-7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33916200&oldid=1766548209"